| human | Q5 |
| P496 | ORCID iD | 0000-0002-3958-5662 |
| P734 | family name | Olfson | Q110795224 |
| Olfson | Q110795224 | ||
| Olfson | Q110795224 | ||
| P735 | given name | Mark | Q13610143 |
| Mark | Q13610143 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q92086754 | 20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings |
| Q57173983 | A Comprehensive Model of Predictors of Suicide Attempt in Depressed Individuals and Effect of Treatment-Seeking Behavior: Results From a National 3-Year Prospective Study |
| Q90934756 | A National Survey of Trends in Health Insurance Coverage of Low-Income Adults Following Medicaid Expansion |
| Q51893587 | A case-control study of antidepressants and attempted suicide during early phase treatment of major depressive episodes. |
| Q50694745 | A characterization of adult victims of sexual violence: results from the national epidemiological survey for alcohol and related conditions. |
| Q34169351 | A comparison of three scales for assessing social functioning in primary care |
| Q40101112 | A comprehensive model of predictors of persistence and recurrence in adults with major depression: Results from a national 3-year prospective study |
| Q101136475 | A comprehensive model of predictors of suicide attempt in individuals with panic disorder: Results from a national 3-year prospective study |
| Q51996066 | A diagnostic aid for detecting (DSM-IV) mental disorders in primary care. |
| Q35499267 | A dimensional liability model of age differences in mental disorder prevalence: evidence from a national sample |
| Q51912113 | A pilot survey of inmate preferences for on-site, visiting consultant, and telemedicine psychiatric services. |
| Q40077297 | A randomized controlled trial to engage in care of adolescent emergency department patients with mental health problems that increase suicide risk |
| Q51940276 | A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. |
| Q57807614 | A randomized trial of interpersonal psychotherapy, problem solving therapy, and supportive therapy for major depressive disorder in women with breast cancer |
| Q97523500 | A stochastic agent-based model of the SARS-CoV-2 epidemic in France |
| Q34133885 | A systematic review of validated methods for identifying depression using administrative data |
| Q34133890 | A systematic review of validated methods for identifying suicide or suicidal ideation using administrative or claims data |
| Q40171669 | Access to Psychosocial Services Prior to Starting Antipsychotic Treatment Among Medicaid-Insured Youth |
| Q91576921 | Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder |
| Q36905070 | Adding or switching antipsychotic medications in treatment-refractory schizophrenia |
| Q48254091 | Addressing suicide risk in emergency department patients |
| Q96110031 | Age and Incidence of Dementia Diagnosis |
| Q47258027 | Age at Exposure to Surgery and Anesthesia in Children and Association With Mental Disorder Diagnosis |
| Q46532224 | An Initiative to Improve Clozapine Prescribing in New York State |
| Q33998345 | Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study |
| Q43975310 | Antidepressant switching among adherent patients treated for depression |
| Q38689268 | Antipsychotic Medication Treatment Patterns in Adult Depression. |
| Q92201819 | Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder |
| Q91885478 | Antipsychotic Use Among Youth in Foster Care Enrolled in a Specialized Managed Care Organization Intervention |
| Q38847674 | Antipsychotic Use Trends in Youth With Autism Spectrum Disorder and/or Intellectual Disability: A Meta-Analysis. |
| Q73899208 | Antipsychotic dosage at hospital discharge and outcomes among persons with schizophrenia |
| Q43661140 | Antipsychotic monotherapy and adjuvant psychotropic therapies in schizophrenia patients: effect on time to readmission |
| Q83257379 | Antipsychotic prescriptions for children and adolescents in the UK increased from 1993 to 2005 |
| Q40362329 | Antipsychotic treatment of adults in the United States |
| Q87291146 | Antipsychotics and the risk of type 2 diabetes mellitus in children and youth |
| Q36777687 | Assault and Mental Disorders: A Cross-Sectional Study of Urban Adult Primary Care Patients |
| Q35962389 | Assessing and improving clinical insight among patients "in denial" |
| Q108832230 | Association between Hydroxyzine Use and Reduced Mortality in Patients Hospitalized for Coronavirus Disease 2019: Results from a multicenter observational study |
| Q91955200 | Association of Suicide and Other Mortality With Emergency Department Presentation |
| Q39672961 | Asthma and mental disorders in primary care |
| Q51921696 | Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia. |
| Q104798620 | Balancing the Risks and Benefits of Benzodiazepines |
| Q96134764 | Benzodiazepine Treatment and Fracture Risk in Young Persons With Anxiety Disorders |
| Q41679520 | Benzodiazepine use in the United States |
| Q35379459 | Best Practices: MEDNET: a multistate policy maker-researcher collaboration to improve prescribing practices |
| Q39735051 | Bipolar depression in a low-income primary care clinic |
| Q37848562 | Bipolar medication use and adherence to antiretroviral therapy among patients with HIV-AIDS and bipolar disorder. |
| Q39590236 | Borderline personality disorder in primary care |
| Q40154933 | Borderline personality disorder, exposure to interpersonal trauma, and psychiatric comorbidity in urban primary care patients |
| Q72609020 | Brief diagnostic interviews (SDDS-PC) for multiple mental disorders in primary care. A pilot study |
| Q34509605 | Brief screening for family psychiatric history: the family history screen |
| Q71618162 | Brief screens for mental disorders in primary care |
| Q43585027 | Bringing antidepressant self-discontinuation into view |
| Q33960193 | Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. |
| Q48007380 | Building The Mental Health Workforce Capacity Needed To Treat Adults With Serious Mental Illnesses |
| Q96031261 | Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others |
| Q44349195 | Cannabis Use and Risk of Prescription Opioid Use Disorder in the United States |
| Q39991004 | Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study |
| Q28729087 | Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study |
| Q64901923 | Causes of Death After Nonfatal Opioid Overdose. |
| Q90405175 | Changes in pharmacotherapeutic approaches in the treatment of bipolar disorder by primary care physicians |
| Q35928745 | Changing profiles of service sectors used for mental health care in the United States |
| Q123142327 | Characteristics and Trends in HIV Testing Among Medicaid Enrollees Diagnosed as Having Schizophrenia |
| Q97567441 | Characterization of the Quality of Electroconvulsive Therapy Among Older Medicare Beneficiaries |
| Q37247849 | Child physical abuse and adult mental health: a national study |
| Q60641491 | Childhood maltreatment and impulsivity as predictors of interpersonal violence, self-injury and suicide attempts: A national study |
| Q61447365 | Childhood psychosocial challenges and risk for obesity in U.S. men and women |
| Q92168101 | Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia |
| Q40368980 | Clozapine for Schizophrenia: State Variation in Evidence-Based Practice. |
| Q51939809 | Cognitive deficits and the course of major depression in a cohort of middle-aged and older community-dwelling adults. |
| Q87646617 | Combination psychotropic regimens in community practice |
| Q43997748 | Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. |
| Q84357179 | Comparative Effectiveness of Adjunctive Psychotropic Medications in Patients With Schizophrenia |
| Q40351255 | Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia |
| Q36121469 | Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia |
| Q35828059 | Comparative safety of antipsychotic medications in nursing home residents |
| Q123600433 | Comparing mental and physical health of U.S. veterans by VA healthcare use: implications for generalizability of research in the VA electronic health records |
| Q51899269 | Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder. |
| Q51922693 | Continuity of antidepressant treatment for adults with depression in the United States. |
| Q48577408 | Continuity of care after inpatient discharge of patients with schizophrenia in the Medicaid program: a retrospective longitudinal cohort analysis |
| Q43648194 | Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder |
| Q91760102 | Contributing Factors to Heterogeneity in the Timing of the Onset of Nonfatal Suicidal Behavior: Results From a Nationally Representative Study |
| Q51889227 | Correlates of help-seeking behavior among at-risk adolescents. |
| Q41522374 | Correlates of intimate partner violence perpetration: results from a National Epidemiologic Survey |
| Q90391486 | Corrigendum to "Developing an opioid use disorder treatment cascade: A review of quality measures" [Journal of Substance Abuse Treatment 91 (2018) 57-68] |
| Q38387644 | Current practices for measuring mental health outcomes in the USA: International overview of routine outcome measures in mental health |
| Q47555240 | Declining Health-Related Quality of Life in the U.S. |
| Q48459590 | Declining use of electroconvulsive therapy in U.S. general hospitals is not restricted to unipolar depression |
| Q37732259 | Declining use of electroconvulsive therapy in United States general hospitals |
| Q34336404 | Delays in initial treatment contact after first onset of a mental disorder |
| Q92747374 | Deliberate self-harm in older adults: A national analysis of US emergency department visits and follow-up care |
| Q39672976 | Depressed mothers coming to primary care: maternal reports of problems with their children |
| Q34723038 | Depression and glycemic control in Hispanic primary care patients with diabetes |
| Q38897389 | Depression care among adults with co-occurring major depressive episodes and substance use disorders in the United States |
| Q38984027 | Depression care among depressed adults with and without comorbid substance use disorders in the United States |
| Q36358501 | Depression in African Americans: breaking barriers to detection and treatment |
| Q36182515 | Depression in US Hispanics: diagnostic and management considerations in family practice. |
| Q71967766 | Depression in women: implications for health care research |
| Q89128932 | Developing an opioid use disorder treatment cascade: A review of quality measures |
| Q72609015 | Development and validation of the SDDS-PC screen for multiple mental disorders in primary care |
| Q91191289 | Development of a Cascade of Care for responding to the opioid epidemic |
| Q46457751 | Diabetes and depression care among medicaid beneficiaries |
| Q44287545 | Diagnosis and treatment of depression in older community-dwelling adults: 1992-2005. |
| Q47674432 | Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers |
| Q44289194 | Diffusion of new generation antidepressant treatment among elderly diagnosed with depression |
| Q40400309 | Distinguishing Between Physiological Dependence and Substance Use Disorder: Response to Ruan et al. |
| Q52816418 | Dr Correll and Colleagues Reply. |
| Q37415067 | Dropout from outpatient mental health care in the United States |
| Q92455437 | E-cigarette Use Among Young Adults in the U.S. |
| Q92975886 | Economic Burden of Treatment-Resistant Depression on the U.S. Health Care System |
| Q92041242 | Editorial: Identifying Youths With Mood Disorders at High Short-Term Risk of Hospital Readmission |
| Q99554371 | Effect of Scheduling a Post-Discharge Outpatient Mental Health Appointment on the Likelihood of Successful Transition From Hospital to Community-Based Care |
| Q37714785 | Effect of first episode axis I disorders on quality of life |
| Q40011382 | Effect of routine mental health screening in a low-resource pediatric primary care population |
| Q57150355 | Effectiveness Research: Transporting Interpersonal Psychotherapy for Depressed Adolescents (IPT-A) From the Lab to School-Based Health Clinics |
| Q88989907 | Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies |
| Q34292633 | Effectiveness of electroconvulsive therapy in community settings |
| Q46818954 | Effects of Food and Drug Administration warnings on antidepressant use in a national sample |
| Q57480323 | Effects of Psychiatric Disorders on Suicide Attempt: Similarities and Differences Between Older and Younger Adults in a National Cohort Study |
| Q91104288 | Effects of the Affordable Care Act on Private Insurance Coverage and Treatment of Behavioral Health Conditions in Young Adults |
| Q41494145 | Electronic health records in mental health research: a framework for developing valid research methods. |
| Q92326082 | Emergency Department Management of Deliberate Self-harm: A National Survey |
| Q38612215 | Emergency Department Recognition of Mental Disorders and Short-Term Risk of Repeat Self-Harm Among Young People Enrolled in Medicaid |
| Q48444422 | Emergency department recognition of mental disorders and short-term outcome of deliberate self-harm |
| Q46975512 | Emergency treatment of deliberate self-harm |
| Q50770328 | Emergency treatment of young people following deliberate self-harm. |
| Q51861637 | Enhancing access through TeenScreen. |
| Q50732643 | Epidemiologic and clinical perspectives on antipsychotic treatment of children and adolescents. |
| Q52003212 | Essential roles for psychiatry in the era of managed care. |
| Q43258382 | Evaluating the Effect of the Changes in FDA Guidelines for Clozapine Monitoring |
| Q51827895 | Evaluating the quality of community care for attention-deficit/hyperactivity disorder. |
| Q41266135 | Evaluation of screens for mental disorders in primary care: methodological issues |
| Q33819692 | Evidence for the management of adolescent depression. |
| Q122002475 | Examining the Impact of State-Level Factors on HIV Testing for Medicaid Enrollees With Schizophrenia |
| Q92551868 | Exposure to Surgery and Anesthesia in Early Childhood and Subsequent Use of Attention Deficit Hyperactivity Disorder Medications |
| Q39031507 | Extent, Time Course, and Moderators of Antipsychotic Treatment in Youth With Mood Disorders: Results of a Meta-Analysis and Meta-Regression Analyses |
| Q47691728 | Facilitating Temporary, Safe Firearms Restrictions Among Individuals at High Risk of Suicide: Response to Sung |
| Q95601203 | Facing the COVID-19 epidemic in NYC: a stochastic agent-based model of various intervention strategies |
| Q34424321 | Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication |
| Q51998649 | False positive results: a challenge for psychiatric screening in primary care. |
| Q91919570 | Family Involvement in Psychiatric Hospitalizations: Associations With Discharge Planning and Prompt Follow-Up Care |
| Q45787485 | Family contact and the management of medication non-adherence in schizophrenia |
| Q35034458 | First treatment contact for ADHD: predictors of and gender differences in treatment seeking |
| Q48354218 | Focusing suicide prevention on periods of high risk |
| Q35809854 | Foster care, externalizing disorders, and antipsychotic use among Medicaid-enrolled youths. |
| Q36824681 | Functional impairment in adults with past posttraumatic stress disorder: findings from primary care |
| Q36932663 | Gender differences in posttraumatic stress disorder among primary care patients after the World Trade Center attack of September 11, 2001 |
| Q37276367 | Gender, HIV status, and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions |
| Q74652828 | General medical problems among the offspring of depressed parents: a 10-year follow-up |
| Q47582630 | Generalizability of Clinical Trial Results for Adolescent Major Depressive Disorder |
| Q60447029 | Generalizability of Clinical Trial Results for Major Depression to Community Samples |
| Q39021871 | Generalizability of Neuroimaging Studies in 5 Common Psychiatric Disorders Based on the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). |
| Q43470545 | Generalizability of clinical trial results for major depression to community samples: results from the National Epidemiologic Survey on Alcohol and Related Conditions |
| Q37128195 | Generalizability of clinical trials for alcohol dependence to community samples |
| Q35582292 | Generalizability of clinical trials for cannabis dependence to community samples |
| Q80526718 | Generalized anxiety disorder, somatic pain and health care costs |
| Q38162752 | Geographic and clinical variation in clozapine use in the United States. |
| Q44400273 | Guideline-consistent antidepressant treatment patterns among veterans with diabetes and major depressive disorder |
| Q34400431 | Health-related quality of life across the anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions (NESARC) |
| Q34484539 | Health-related quality of life following ECT in a large community sample |
| Q34017861 | Higher-risk periods for suicide among VA patients receiving depression treatment: prioritizing suicide prevention efforts |
| Q45934694 | Hyperlipidemia following treatment with antipsychotic medications. |
| Q104752456 | Identification of Suicide Attempt Risk Factors in a National US Survey Using Machine Learning |
| Q39938286 | Identifying adolescents at risk through voluntary school-based mental health screening |
| Q93177585 | If You Could Change 1 Thing to Improve the Quality of Emergency Care for Deliberate Self-harm Patients, What Would It Be? A National Survey of Nursing Leadership |
| Q94510977 | Impact Of Long-Term Buprenorphine Treatment On Adverse Health Care Outcomes In Medicaid |
| Q90772368 | Impact Of Medicaid Expansion On Coverage And Treatment Of Low-Income Adults With Substance Use Disorders |
| Q95306491 | Impact of Around-the-Clock Mental Health Staffing on Emergency Department Management of Patients Who Deliberately Self-Harm |
| Q39659014 | Improving the detection of drug abuse, alcohol abuse, and depression in community health centers |
| Q31139239 | Incentivizing Data Sharing and Collaboration in Medical Research-The S-Index |
| Q92045918 | Incident Substance Use Disorder Following Anxiety Disorder in Privately Insured Youth |
| Q35778650 | Influence of comorbid mental disorders on time to seeking treatment for major depressive disorder |
| Q36969976 | Injury among stimulant-treated youth with ADHD. |
| Q91760370 | Insomnia and Impaired Quality of Life in the United States |
| Q36155412 | Interpersonal Counseling (IPC) for Depression in Primary Care |
| Q33961708 | Interventions to improve medication adherence in schizophrenia |
| Q91346891 | Invasive mechanical ventilation for people with severe mental disorders: recent trends in incidence and in-hospital mortality |
| Q44730185 | Investing in evidence-based care for the severely mentally ill. |
| Q100493983 | Is Cannabis being used as a substitute for non-medical opioids by adults with problem substance use in the United States? A within-person analysis |
| Q35622010 | Length of stay of pediatric mental health emergency department visits in the United States |
| Q43096522 | Link between FDA antidepressant warnings and increased suicide attempts in young people is questionable |
| Q45061715 | Listening to generic Prozac: winners, losers, and sideliners |
| Q54295119 | Lithium treatment and risk for dementia in adults with bipolar disorder: population-based cohort study. |
| Q95626207 | Lockdown exit strategies and risk of a second epidemic peak: a stochastic agent-based model of SARS-CoV-2 epidemic in France |
| Q36798810 | Long-term course of probable PTSD after the 9/11 attacks: a study in urban primary care |
| Q44312958 | Major depression in community-dwelling middle-aged and older adults: prevalence and 2- and 4-year follow-up symptoms |
| Q39768271 | Major depressive disorder, somatic pain, and health care costs in an urban primary care practice |
| Q46377274 | Male sexual dysfunction and quality of life in schizophrenia. |
| Q47389744 | Management of Common Medical Conditions by Office-Based Psychiatrists |
| Q40178730 | Management of Mental Health Crises Among Youths With and Without ASD: A National Survey of Child Psychiatrists |
| Q37184144 | Mapping common psychiatric disorders: structure and predictive validity in the national epidemiologic survey on alcohol and related conditions |
| Q56243478 | Mapping risk factors for depression across the lifespan: An umbrella review of evidence from meta-analyses and Mendelian randomization studies |
| Q43694676 | Measuring the need for mental health care |
| Q101406302 | Medicaid Expansion and Low-Income Adults with Substance Use Disorders |
| Q52681084 | Medical Marijuana and the Opioid Epidemic: Response to Theriault and Schlesinger. |
| Q96771310 | Medical comorbid diagnoses among adult psychiatric inpatients |
| Q39567204 | Medically unexplained symptoms in an urban general medicine practice |
| Q92748626 | Medication And Substance Abuse: The Authors Reply |
| Q90921269 | Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities |
| Q73732058 | Medication costs, adherence, and health outcomes among Medicare beneficiaries |
| Q50723536 | Medication use in US youth with mental disorders. |
| Q58607826 | Medications With Depression as an Adverse Effect-Reply |
| Q29029559 | Mental Health Screening and Follow-up Care in Public High Schools |
| Q29398674 | Mental Health of College Students and Their Non–College-Attending Peers |
| Q36936081 | Mental and physical health consequences of the September 11, 2001 (9/11) attacks in primary care: a longitudinal study |
| Q51997859 | Mental disorders and disability among patients in a primary care group practice. |
| Q91229981 | Mental health delivery in primary care: The perspectives of primary care providers |
| Q35486273 | Mental health of victims of intimate partner violence: results from a national epidemiologic survey |
| Q28237263 | Mental health screening of African American adolescents and facilitated access to care |
| Q28272208 | Mental health screening of adolescents in pediatric practice |
| Q37569353 | Mental health treatment received by youths in the year before and after a new diagnosis of bipolar disorder |
| Q64058171 | Meta-analysis of suicide rates in the first week and the first month after psychiatric hospitalisation |
| Q30966054 | Methodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data |
| Q91364369 | Misuse of prescribed opioids in the United States |
| Q94601108 | Mortality Following Nonfatal Opioid and Sedative/Hypnotic Drug Overdose |
| Q100391667 | Mortality risk of antipsychotic augmentation for adult depression |
| Q47551192 | National Patterns of Commonly Prescribed Psychotropic Medications to Young People |
| Q47376054 | National Trends In Specialty Outpatient Mental Health Care Among Adults |
| Q34187891 | National Trends in Child and Adolescent Psychotropic Polypharmacy in Office-Based Practice, 1996-2007 |
| Q90646528 | National Trends in Mental Health Care for US Adolescents |
| Q38443553 | National Trends in Outpatient Psychotherapy |
| Q40043234 | National Trends in Suicide Attempts Among Adults in the United States |
| Q39111492 | National Trends in the Prevalence and Treatment of Depression in Adolescents and Young Adults |
| Q38449365 | National patterns in antidepressant medication treatment |
| Q46655034 | National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the national comorbidity survey replication. |
| Q45973641 | National patterns in the outpatient pharmacological management of children and adolescents with autism spectrum disorder. |
| Q92749089 | National study of emergency department disposition for high suicide risk geriatric patients |
| Q44296087 | National trends in ethnic disparities in mental health care |
| Q40528612 | National trends in hospital-treated self-harm events among middle-aged adults |
| Q46580874 | National trends in hospitalization of youth with intentional self-inflicted injuries |
| Q45220572 | National trends in long-term use of antidepressant medications: results from the U.S. National Health and Nutrition Examination Survey |
| Q34804065 | National trends in psychotherapy by office-based psychiatrists |
| Q34090959 | National trends in psychotropic medication polypharmacy in office-based psychiatry |
| Q45992124 | National trends in second-generation antipsychotic augmentation for nonpsychotic depression. |
| Q51167835 | National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disorders. |
| Q50674398 | National trends in the mental health care of children, adolescents, and adults by office-based physicians. |
| Q48416603 | National trends in the office-based prescription of schedule II opioids |
| Q48631822 | National trends in the office-based treatment of children, adolescents, and adults with antipsychotics |
| Q28244462 | National trends in the outpatient diagnosis and treatment of bipolar disorder in youth |
| Q35887441 | National trends in the outpatient treatment of anxiety disorders. |
| Q51801492 | National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. |
| Q34108086 | National trends in the outpatient treatment of depression |
| Q44070024 | National trends in the treatment for depression from 1998 to 2007. |
| Q28207694 | National trends in the treatment of attention deficit hyperactivity disorder |
| Q34986143 | National trends in the use of outpatient psychotherapy |
| Q43996317 | National trends in the use of psychotropic medications by children |
| Q53024432 | Neonatal risks of maternal treatment with mood stabilizers. |
| Q35880190 | New options in the pharmacological management of attention-deficit/hyperactivity disorder. |
| Q39158839 | No End in Sight: Benzodiazepine Use in Older Adults in the United States |
| Q123600449 | Non-pharmacological Treatment for Chronic Pain in US Veterans Treated Within the Veterans Health Administration: Implications for Expansion in US Healthcare Systems |
| Q56698295 | Offspring of Depressed Parents |
| Q36837691 | Older, Less Regulated Medical Marijuana Programs Have Much Greater Enrollment Rates Than Newer 'Medicalized' Programs |
| Q92132812 | Opioid Use and Misuse and Suicidal Behaviors in a Nationally Representative Sample of US Adults |
| Q90159579 | Opioid and Benzodiazepine Coprescribing in the United States Before and After US Food and Drug Administration Boxed Warning |
| Q53316741 | Opioids and Other Central Nervous System-Active Polypharmacy in Older Adults in the United States. |
| Q91646869 | Opportunities for Improving Access to Evidence-Based Treatments of Depression |
| Q47679121 | Outpatient Follow-Up Care and Risk of Hospital Readmission in Schizophrenia and Bipolar Disorder |
| Q37076234 | Outpatient antipsychotic treatment and inpatient costs of schizophrenia |
| Q48563639 | Outpatient care of young people after emergency treatment of deliberate self-harm |
| Q104286950 | Outpatient prescribing of opioids to adults diagnosed with mental disorders in the United States |
| Q35603169 | Outpatient treatment of child and adolescent depression in the United States |
| Q47653903 | Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993-2014. |
| Q57150297 | PTSD in urban primary care patients following 9/11 |
| Q39573806 | Pain as a Predictor of Opioid Use Disorder in a Nationally Representative Sample |
| Q123600456 | Pain, cannabis use, and physical and mental health indicators among veterans and nonveterans: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III |
| Q39588212 | Panic and suicidal ideation in primary care |
| Q36781001 | Panic disorder and suicidal ideation in primary care |
| Q47877171 | Parental depression, child mental health problems, and health care utilization |
| Q51892612 | Parental detection of youth's self-harm behavior. |
| Q44885217 | Patients' early discontinuation of antidepressant prescriptions |
| Q51157362 | Patterns and correlates of tic disorder diagnoses in privately and publicly insured youth. |
| Q44908897 | Patterns and quality of treatment for patients with schizophrenia in routine psychiatric practice |
| Q51751545 | Payment source and emergency management of deliberate self-harm. |
| Q48652251 | Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders |
| Q28295134 | Pharmacoepidemiology of antipsychotic use in youth with ADHD: trends and clinical implications |
| Q36711426 | Poor health-related quality of life prior to ECT in depressed patients normalizes with sustained remission after ECT. |
| Q30559039 | Positive predictive value of a case definition for diabetes mellitus using automated administrative health data in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid study |
| Q36894950 | Positive screens for psychiatric disorders in primary care: a long-term follow-up of patients who were not in treatment |
| Q36755278 | Posttraumatic stress disorder in primary care one year after the 9/11 attacks |
| Q37709983 | Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD. |
| Q39701187 | Predicting psychiatric hospital admission among adults with schizophrenia |
| Q96165278 | Predictors of suicide at time of diagnosis in schizophrenia spectrum disorder: A 20-year total population study in Ontario, Canada |
| Q41176091 | Premature Mortality Among Adults With Schizophrenia in the United States. |
| Q36930857 | Prescribing of psychotropic medications to children and adolescents: quo vadis? |
| Q91382558 | Prescription Benzodiazepine Use in Privately Insured U.S. Children and Adolescents |
| Q123600455 | Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III) |
| Q35256219 | Prevalence and correlates of anger in the community: results from a national survey |
| Q27028197 | Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment |
| Q36457244 | Prevalence and correlates of child sexual abuse: a national study |
| Q33760833 | Prevalence and treatment of mental disorders, 1990 to 2003 |
| Q61440650 | Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States |
| Q96834363 | Prevalence of Treatment for Depression Among US Adults Who Screen Positive for Depression, 2007-2016 |
| Q33921461 | Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice |
| Q52013435 | Prevalence of mental disorders in primary care. Implications for screening. |
| Q100508887 | Private health insurance coverage of drug use disorder treatment: 2005-2018 |
| Q30713451 | Probability and predictors of first treatment contact for anxiety disorders in the United States: analysis of data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). |
| Q36794523 | Probability and predictors of treatment-seeking for prescription opioid use disorders: a national study. |
| Q36682087 | Probability and predictors of treatment-seeking for substance use disorders in the U.S. |
| Q51922799 | Prolonged duration of untreated psychosis in nonaffective first-episode psychotic disorders compared to other psychoses. |
| Q46113035 | Proportion of antidepressants prescribed without a psychiatric diagnosis is growing |
| Q51410044 | Prospective Service Use and Health Care Costs of Medicaid Beneficiaries with Treatment-Resistant Depression. |
| Q47922228 | Providing Mental Health Care: The Author Replies |
| Q39434020 | Psychiatric Inpatient Discharge Planning Practices and Attendance at Aftercare Appointments |
| Q52317755 | Psychiatric Services and "the Homeless": Changing the Paradigm. |
| Q92215300 | Psychiatric disorders and risk for multiple adverse outcomes: a national prospective study |
| Q37158826 | Psychiatric disorders in pregnant and postpartum women in the United States |
| Q44029100 | Psychiatric opinion and antipsychotic selection in the management of schizophrenia |
| Q96433167 | Psychological Aspects of the COVID-19 Pandemic |
| Q52012211 | Psychological management by family physicians. |
| Q79828621 | Psychosocial functioning of Medicaid recipients with major depression |
| Q39610209 | Psychotic symptoms in an urban general medicine practice |
| Q39435585 | Psychotic symptoms in primary care. |
| Q52615514 | Psychotropic Medication Use Among Adults With Schizophrenia and Schizoaffective Disorder in the United States. |
| Q46186178 | Psychotropic medication patterns among youth in juvenile justice |
| Q36877283 | Psychotropic medication treatment of adolescents: results from the National Comorbidity Survey-Adolescent Supplement |
| Q48226768 | Quality of life following remission of mental disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions |
| Q44612987 | Race and the clinical diagnosis of depression in new primary care patients |
| Q53650697 | Racial and ethnic disparities in depression care in community-dwelling elderly in the United States. |
| Q36234358 | Racial differences in the availability and use of electroconvulsive therapy for recurrent major depression |
| Q44067876 | Racial differences in visit duration of outpatient psychiatric visits |
| Q92604284 | Racial-Ethnic Differences in Service Use Patterns Among Young, Commercially Insured Individuals With Recent-Onset Psychosis |
| Q39705358 | Rapid Growth Of Antipsychotic Prescriptions For Children Who Are Publicly Insured Has Ceased, But Concerns Remain |
| Q41681618 | Re-examining antidepressant risk of self-injury in children and adolescents. |
| Q52016621 | Recognition of emotional distress in physically healthy primary care patients who perceive poor physical health. |
| Q38187797 | Referral and follow-up after mental health screening in commercially insured adolescents |
| Q47444850 | Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents |
| Q90569543 | Relationship Between Continuity of Care and Discharge Planning After Hospital Psychiatric Admission |
| Q113260384 | Research Opportunities That Maximize Public Health Impact on the Opioid Overdose Epidemic |
| Q51974692 | Response to Drs Abrams and Kellner: the cognitive effects of ECT in community settings. |
| Q37621111 | Review: limited evidence to support specialist mental health services as alternatives to inpatient care for young people with severe mental health disorders |
| Q57785613 | Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees |
| Q36915942 | Risk of readmission in compulsorily and voluntarily admitted patients |
| Q95309248 | Risks of Mortality Following Nonfatal Intentional and Unintentional Opioid Overdoses |
| Q90039480 | Risks of fatal opioid overdose during the first year following nonfatal overdose |
| Q46868669 | SSRI prescriptions and the rate of suicide |
| Q47953745 | Screening for Depression Through a Glass Darkly-Reply |
| Q36053183 | Screening for bipolar disorder in a primary care practice |
| Q36800654 | Screening for generalized anxiety disorder symptoms in the wake of terrorist attacks: a study in primary care |
| Q92513648 | Self-Harm, Suicidal Ideation, and Attempted Suicide in Older Adults: A National Study of Emergency Department Visits and Follow-Up Care |
| Q52662505 | Self-medication of mood and anxiety disorders with marijuana: Higher in states with medical marijuana laws. |
| Q44208563 | Self-perception of poor health and suicidal ideation in medical patients |
| Q91777211 | Service Use Following First-Episode Schizophrenia Among Commercially Insured Youth |
| Q47570268 | Service Use Preceding Opioid-Related Fatality |
| Q37373527 | Service implications of providing intensive monitoring during high-risk periods for suicide among VA patients with depression |
| Q34154840 | Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A). |
| Q90188153 | Sex differences on the relation between major depressive disorder and labor market outcomes: A national prospective study |
| Q93106972 | Shared and specific associations of substance use disorders on adverse outcomes: A national prospective study |
| Q39365917 | Short-term Suicide Risk After Psychiatric Hospital Discharge |
| Q94474503 | Sleep complaints are associated with increased suicide risk independently of psychiatric disorders: results from a national 3-year prospective study |
| Q98473859 | Social Media Use and Depressive Symptoms Among United States Adolescents |
| Q39716191 | Social anxiety disorder in primary care |
| Q95276935 | Sociodemographic Factors Associated With High Risk for Firearm Suicide Among US Adults |
| Q63214486 | State variations in Medicaid enrollment and utilization of substance use services: Results from a National Longitudinal Study |
| Q41529678 | Stimulant Treatment of Young People in the United States |
| Q46121326 | Stimulant dosing for children with ADHD: a medical claims analysis |
| Q46698354 | Stimulant dosing in the community treatment of adult attention-deficit/hyperactivity disorder |
| Q33160890 | Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder |
| Q50877379 | Subjective evaluation of the therapeutic and cognitive effects of electroconvulsive therapy. |
| Q46882537 | Subjective unmet need for mental health services in depressed children grown up. |
| Q43551609 | Substance abuse and the management of medication nonadherence in schizophrenia |
| Q123600443 | Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records |
| Q46112224 | Subthreshold psychiatric symptoms in a primary care group practice |
| Q45968311 | Sudden death and use of stimulant medications in youths. |
| Q97415727 | Suicidal ideation and attempts following nonmedical use of prescription opioids and related disorder |
| Q46077733 | Suicidal ideation in primary care |
| Q51761651 | Suicide After Deliberate Self-Harm in Adolescents and Young Adults. |
| Q38893058 | Suicide Following Deliberate Self-Harm |
| Q47870867 | Suicide Risk After Psychiatric Hospital Discharge |
| Q91894420 | Suicides Among Opioid Overdose Deaths-Reply |
| Q50592743 | Surveillance of adverse psychiatric medication events. |
| Q36702297 | Testing the drug substitution switching-addictions hypothesis. A prospective study in a nationally representative sample |
| Q91616566 | The Affordable Care Act and Opioid Agonist Therapy for Opioid Use Disorder |
| Q104507446 | The Neurobiology of Treatment-Resistant Schizophrenia: Paths to Antipsychotic Resistance and A Roadmap for Future Research |
| Q91358518 | The Relationship Between Evidence-Based Practices and Emergency Department Managers' Perceptions on Quality of Care for Self-Harm Patients |
| Q38669123 | The Relevance of the Affordable Care Act for Improving Mental Health Care |
| Q48034139 | The Rise of Primary Care Physicians in the Provision of US Mental Health Care |
| Q49141035 | The SDDS-PC: a diagnostic aid for multiple mental disorders in primary care |
| Q38978919 | The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence |
| Q34561037 | The cognitive effects of electroconvulsive therapy in community settings |
| Q36841268 | The mental health consequences of disaster-related loss: findings from primary care one year after the 9/11 terrorist attacks |
| Q51710709 | The most expensive medical conditions in America. |
| Q92480512 | The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research |
| Q50591600 | The popularity of benzodiazepines, their advantages, and inadequate pharmacological alternatives-reply. |
| Q34987287 | The space of common psychiatric disorders in adolescents: comorbidity structure and individual latent liabilities |
| Q37019471 | The use of clinical trials in comparative effectiveness research on mental health |
| Q91087060 | Tobacco Screening and Counseling in the U.S.: Smokers With Mental Health and Substance Use Problems |
| Q33852341 | Toward National Estimates of Effectiveness of Treatment for Substance Use |
| Q92041958 | Toward a Comprehensive Developmental Model of Prescription Opioid Use Disorder |
| Q36421771 | Training community-based primary care physicians in the screening and management of mental health disorders among Latino primary care patients |
| Q64229352 | Transforming Mental Health Delivery Through Behavioral Economics and Implementation Science: Protocol for Three Exploratory Projects |
| Q33994504 | Translating intergenerational research on depression into clinical practice |
| Q36786370 | Trauma exposure and posttraumatic stress disorder among primary care patients with bipolar spectrum disorder |
| Q39443801 | Treatment of Adult Depression in the United States |
| Q92372986 | Treatment of Common Mental Disorders in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III |
| Q38413873 | Treatment of Young People With Antipsychotic Medications in the United States |
| Q55042213 | Treatment of obsessive-compulsive disorder by U.S. psychiatrists. |
| Q33734927 | Treatment of obsessive-compulsive disorder in a nationwide survey of office-based physician practice |
| Q37427122 | Treatment of schizophrenia with long-acting fluphenazine, haloperidol, or risperidone |
| Q51872875 | Treatment patterns for schizoaffective disorder and schizophrenia among Medicaid patients. |
| Q47207659 | Treatment seeking for depression in Canada and the United States |
| Q92437528 | Trends In Opioid Prescribing And Self-Reported Pain Among US Adults |
| Q92798781 | Trends in Buprenorphine Treatment in the United States, 2009-2018 |
| Q123600435 | Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration, 2005-2019 |
| Q34680769 | Trends in Central Nervous System-Active Polypharmacy Among Older Adults Seen in Outpatient Care in the United States |
| Q92040186 | Trends in Intentional and Unintentional Opioid Overdose Deaths in the United States, 2000-2017 |
| Q50599873 | Trends in Mental Health Care among Children and Adolescents. |
| Q123600445 | Trends in Prescriptions for Non-opioid Pain Medications Among U.S. Adults With Moderate or Severe Pain, 2014-2018 |
| Q93365434 | Trends in Serious Psychological Distress and Outpatient Mental Health Care of US Adults |
| Q39893516 | Trends in antipsychotic drug use by very young, privately insured children |
| Q34169478 | Trends in care by nonphysician clinicians in the United States |
| Q43512575 | Trends in elderly patients' office visits for the treatment of depression according to physician specialty: 1985-1999. |
| Q41727134 | Trends in mental health care among children and adolescents |
| Q34414499 | Trends in office-based mental health care provided by psychiatrists and primary care physicians |
| Q45963635 | Trends in office-based treatment of adults with stimulants in the United States. |
| Q51908371 | Trends in the inpatient mental health treatment of children and adolescents in US community hospitals between 1990 and 2000. |
| Q48526815 | Trends in the prevalence of tobacco use in the United States, 1991-1992 to 2004-2005. |
| Q44013090 | Trends in the treatment of bipolar disorder by outpatient psychiatrists |
| Q37400348 | Twelve-month suicidal symptoms and use of services among adolescents: results from the National Comorbidity Survey |
| Q51929408 | Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. |
| Q38705205 | Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis |
| Q92817724 | U.S. Adults With Pain, a Group Increasingly Vulnerable to Nonmedical Cannabis Use and Cannabis Use Disorder: 2001-2002 and 2012-2013 |
| Q36176732 | Understanding mental health treatment in persons without mental diagnoses: results from the National Comorbidity Survey Replication |
| Q94496639 | Use and outcomes of mechanical ventilation for people with severe mental disorders admitted due to natural causes: A nationwide population-based study |
| Q60447043 | Use of Psychotropic Medications for Patients With Office Visits Who Receive a Diagnosis of Panic Disorder |
| Q50732813 | Use of clozapine in a state child and adolescent psychiatric hospital. |
| Q36842947 | Use of depot antipsychotic medications for medication nonadherence in schizophrenia |
| Q90587176 | Use of marijuana exclusively for medical purposes |
| Q36525583 | Use of outpatient mental health services by depressed and anxious children as they grow up. |
| Q34066966 | Use of psychotherapy for depression in older adults |
| Q89611156 | Using filled prescription sequences to rank antidepressants according to their acceptability in the general population: The Constances cohort |
| Q30696173 | Using state administrative and pharmacy data bases to develop a clinical decision support tool for schizophrenia guidelines. |
| Q35801221 | Validation of a claims-based antipsychotic polypharmacy measure |
Search more.